Clinical Trial Update: Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer

View source ↗

Summary

This clinical trial update reports on racial and genetic biomarkers of response in tissue samples from patients with endometrial cancer across stages I–IV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer | Status: COMPLETED